S.2.1 Identifying and quantifying prognostic factors in SSc-related interstitial lung disease using a time-varying covariate survival model

Autor:	O. Moore, N. Goh, T. Corte, H. Rouse, O. Hennessy, J. Byron, V. Thakkar, J. Sahhar, J. Roddy, P. Youssef, P. Nash, J. Zochling, S. Proudman, W. Stevens, M. Nikpour, E. Tourkina, S. Dyer, C. Reese, J. C. Oates, A. Hofbauer, M. Bonner, R. P. Visconti, J. Zhang, R. M. Silver, S. Hoffman, X. Liu, M. Mayes, F. Tan, B. Harper, E. Gonzalez, H. Draeger, R. Sharif, J. Reveille, F. Arnett, S. Assassi, G. Bogatkevich, T. Akter, I. Atanelishvili, J. Liang, D. Spyropoulos, R. Silver
Rok vydání:	2012
Předmět:	Oncology Time-varying covariate medicine.medical_specialty Pathology business.industry Interstitial lung disease medicine.disease Systemic scleroderma Pulmonary function testing Illness length Outcome variable Rheumatology Internal medicine Medicine Pharmacology (medical) business Survival analysis
Zdroj:	Rheumatology. 51:ii3-ii5
ISSN:	1462-0332 1462-0324
DOI:	10.1093/rheumatology/ker468
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_________::2b0978bc4c830e7809e81ab4a9b478a1 https://doi.org/10.1093/rheumatology/ker468 Zobrazit plný text záznamu